Inventor
STANGELAND ERIC L
US47 patents
⚠️ This page may combine multiple inventors who share the name “STANGELAND ERIC L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
STANGELAND ERIC L
14 patentsUS8247433B2Aug 21, 2012
Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
STANGELAND ERIC L23 citations96
US9012460B2Apr 21, 2015
1-(2-phenoxymethylphenyl)piperazine compounds
STANGELAND ERIC L7 citations84
US8802857B2Aug 12, 2014
Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
STANGELAND ERIC L4 citations84
US8778949B2Jul 15, 2014
1-(2-phenoxymethylphenyl)piperazine compounds
STANGELAND ERIC L7 citations84
US8530663B2Sep 10, 2013
1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds
STANGELAND ERIC L8 citations84
US8242164B2Aug 14, 2012
3-(phenoxyphenylmethyl)pyrrolidine compounds
STANGELAND ERIC L9 citations84
US9187423B2Nov 17, 2015
Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
STANGELAND ERIC L2 citations74
US8471040B2Jun 25, 2013
Serotonin reuptake inhibitors
STANGELAND ERIC L3 citations63
US9000191B2Apr 7, 2015
Serotonin reuptake inhibitors
STANGELAND ERIC L0 citations52
US8933249B2Jan 13, 2015
3-(phenoxyphenylmethyl)pyrrolidine compounds
STANGELAND ERIC L0 citations52
US8853255B2Oct 7, 2014
3-phenoxymethylpyrrolidine compounds
STANGELAND ERIC L0 citations52
US8729119B2May 20, 2014
Serotonin reuptake inhibitors
STANGELAND ERIC L0 citations52
US8637568B2Jan 28, 2014
Serotonin reuptake inhibitors
STANGELAND ERIC L0 citations52
US8501964B2Aug 6, 2013
Serotonin reuptake inhibitors
STANGELAND ERIC L1 citations52
THERAVANCE INC
9 patentsUS7262205B2Aug 28, 2007
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC50 citations96
US8816088B2Aug 26, 2014
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
THERAVANCE INC7 citations93
US7683173B2Mar 23, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC23 citations93
US7642355B2Jan 5, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC32 citations93
US7629336B2Dec 8, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC29 citations93
US7479562B2Jan 20, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC39 citations93
US7888386B2Feb 15, 2011
3-(phenoxyphenylmethyl)pyrrolidine compounds
THERAVANCE INC30 citations92
US7851631B2Dec 14, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC15 citations92
US7868175B2Jan 11, 2011
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC11 citations84
THERAVANCE BIOPHARMA R&D IP LLC
7 patentsUS10722504B2Jul 28, 2020
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
THERAVANCE BIOPHARMA R&D IP LLC5 citations93
US10441579B2Oct 15, 2019
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
THERAVANCE BIOPHARMA R&D IP LLC7 citations93
US10206913B2Feb 19, 2019
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
THERAVANCE BIOPHARMA R&D IP LLC11 citations93
US10034870B2Jul 31, 2018
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
THERAVANCE BIOPHARMA R&D IP LLC12 citations93
US10946007B2Mar 16, 2021
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
THERAVANCE BIOPHARMA R&D IP LLC2 citations84
US11723900B2Aug 15, 2023
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
THERAVANCE BIOPHARMA R&D IP LLC0 citations73
US9260414B2Feb 16, 2016
Inhibitors of hepatitic C virus
THERAVANCE BIOPHARMA R&D IP LLC0 citations50
THERAVANCE RESPIRATORY CO LLC
5 patentsUS9975875B2May 22, 2018
Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC4 citations84
US9771350B2Sep 26, 2017
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC4 citations84
US9682957B2Jun 20, 2017
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC5 citations84
US9572802B2Feb 21, 2017
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC5 citations84
US10138220B1Nov 27, 2018
Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC1 citations62
PATTERSON LORI JEAN
4 patentsUS9675599B2Jun 13, 2017
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
PATTERSON LORI JEAN17 citations96
US9162982B2Oct 20, 2015
4-[2-(2-fluorophenoxy methyl)phenyl]piperidine compounds
PATTERSON LORI JEAN15 citations96
US8604058B2Dec 10, 2013
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
PATTERSON LORI JEAN20 citations96
US8304432B2Nov 6, 2012
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
PATTERSON LORI JEAN25 citations96